(Total Views: 747)
Posted On: 12/05/2020 10:45:08 PM
Post# of 153903
Re: Riztheinvestor #67082
“So wait when do you think the 28 day unblinding will be and if we get EAU on that any idea of the share price?”
Honestly, my guess is as good as yours. The 21st of December is 28 days for the last patient and I believe the last interim analysis PR was released 2 weeks or so after the last patient. That puts the PR around January 5th, assuming timelines stay the same.
In regards to the share price, it all depends on what the PR says. There’s only 2 options: The DSMC recommends halting the trial for efficacy or the DSMC recommends continuing the trial to full enrollment. Halting the trial for efficacy will likely increase the SP (I’m unsure how much) and a recommendation to fully enroll the trial will likely result in a stable or decreased SP.
Honestly, my guess is as good as yours. The 21st of December is 28 days for the last patient and I believe the last interim analysis PR was released 2 weeks or so after the last patient. That puts the PR around January 5th, assuming timelines stay the same.
In regards to the share price, it all depends on what the PR says. There’s only 2 options: The DSMC recommends halting the trial for efficacy or the DSMC recommends continuing the trial to full enrollment. Halting the trial for efficacy will likely increase the SP (I’m unsure how much) and a recommendation to fully enroll the trial will likely result in a stable or decreased SP.
(0)
(0)
